These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3098416)

  • 1. Identification of 5-S-cysteinyldopa by high performance liquid chromatography in biopsies from patients with dysplastic melanocytic nevi.
    Halldin MM; Cook WS; Kawashima T; Crutcher WA; Fukuyama K
    Cancer Res; 1987 Jan; 47(2):636-8. PubMed ID: 3098416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UVB-induced melanocyte proliferation and 5-S-cysteinyldopa excretion in dysplastic nevus syndrome.
    Stierner U; Augustsson A; Rosdahl I; Kågedal B; Suurküla M
    Photodermatol; 1988 Oct; 5(5):218-23. PubMed ID: 3146749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the occurrence of cysteinyldopa and dopa in melanocytes and benign nevi cells.
    Falck B; Jacobsson S; Lindvall O; Nietsche UB
    Scand J Plast Reconstr Surg; 1976; 10(3):185-8. PubMed ID: 1053447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-S-Cysteinyldopa and dopa in serum during treatment with 8-methoxypsoralen and UVA light.
    Hansson C; Rorsman H; Rosengren E; Tegner E
    Acta Derm Venereol; 1981; 61(3):251-5. PubMed ID: 6167110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of DOPA, dopamine, and 5-S-cysteinyl-DOPA in plasma, urine, and tissue samples by high-performance liquid chromatography with electrochemical detection.
    Ito S; Kato T; Maruta K; Fujita K; Kurahashi T
    J Chromatogr; 1984 Nov; 311(1):154-9. PubMed ID: 6440898
    [No Abstract]   [Full Text] [Related]  

  • 6. 5-S-cysteinyldopa as a substrate for tyrosinase.
    Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(5):399-402. PubMed ID: 6162310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical diagnoses of malignant melanomas with determinations of 5-S-cysteinyldopa in lesions].
    Sameshima T; Morishima T
    Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):665-72. PubMed ID: 2511358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopa and 5-S-cysteinyldopa in the serum of albino, black, and red guinea pigs.
    Hansson C; Agrup G; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(2):155-56. PubMed ID: 6155023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma 5-S-cysteinyldopa concentrations in oculocutaneous albinism.
    Nimmo JE; Hunter JA; Percy-Robb IW; Jay B; Phillips CI; Taylor WO
    Acta Derm Venereol; 1985; 65(2):169-71. PubMed ID: 2408424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular distribution of dopa and 5-S-cysteinyldopa in Harding-Passey melanoma.
    Agrup G; Falck B; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1977; 57(4):313-5. PubMed ID: 70922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diastereomers of 5-S-cysteinyldopa.
    Agrup G; Edholm LE; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(1):59-61. PubMed ID: 6191491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.
    Agrup G; Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(1):63-4. PubMed ID: 6153836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid-chromatographic determination of 5-S-L-cysteinyl-L-dopa with electrochemical detection in urine prepurified with a phenylboronate affinity gel.
    Kågedal B; Pettersson A
    Clin Chem; 1983 Dec; 29(12):2031-4. PubMed ID: 6416708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM; Miller S; Gunder M
    Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 5-S-L-cysteinyl-glycine-L-dopa, a natural substrate for serum and melanocyte dipeptidase.
    Kågedal B; Gawelin AL; Pettersson A
    Anal Biochem; 1987 Aug; 165(1):167-74. PubMed ID: 3120620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quantitative determination of 5-S-cysteinyldopa and dopa in normal serum and in serum from patients with malignant melanoma by means of high-pressure liquid chromatography.
    Hansson C; Edholm LE; Agrup G; Rorsman H; Rosengren AM; Rosengren E
    Clin Chim Acta; 1978 Sep; 88(3):419-27. PubMed ID: 699334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.
    Morishima T; Tatsumi F; Fukada E; Saito M; Fujita M; Nagashima N; Hanawa S
    Arch Dermatol Res; 1983; 275(2):76-9. PubMed ID: 6409012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved solid-phase extraction and liquid chromatography with electrochemical detection of urinary catecholamines and 5-S-L-cysteinyl-L-dopa.
    Huang TH; Wall J; Kabra P
    J Chromatogr; 1988 Oct; 452():409-18. PubMed ID: 3149647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
    Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
    Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved method for analysis of cysteinyldopa in human serum.
    Arstrand K; Kullman A; Andersson R; Rasmuson T; Kågedal B
    Scand J Clin Lab Invest; 2004; 64(6):559-64. PubMed ID: 15370461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.